Surgical treatment of oesophageal cancer

Digestive Diseases

Volumn 22, Issue 2, 2004, Pages 213-220

  Hartel, Mark ^a   Wente, Moritz N ^a   Büchler, Markus W ^a   Friess, Helmut ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Adjuvant and neoadjuvant therapy; Oesophageal carcinoma; Oesphageal resection; Reconstruction after oesophagus resection

Indexed keywords

ARTICLE; DYSPHAGIA; ESOPHAGUS CARCINOMA; ESOPHAGUS RESECTION; GASTROPLASTY; HUMAN; LAMINA PROPRIA; MORBIDITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; STOMACH TUBE; TUMOR RECURRENCE;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; ESOPHAGEAL NEOPLASMS; GASTROPLASTY; HUMANS; NEOPLASM RECURRENCE, LOCAL; RECONSTRUCTIVE SURGICAL PROCEDURES;

EID: 4644318931     PISSN: 02572753     EISSN: None     Source Type: Journal    
DOI: 10.1159/000080322     Document Type: Article

References (71)

1. Lagergren J, Bergstrom R, Lindgren A, Nyren O: Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999;340:825-831.
2. Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun MJ: Cancer statistics, 2003. CA Cancer J Clin 2003;53:5-26.
3. Zhu ZW, Friess H, Wang L, Di Mola FF, Zimmermann A, Buchler MW: Down-regulation of nerve growth factor in poorly differentiated and advanced human esophageal cancer. Anticancer Res 2000;20:125-132.
4. Koliopanos A, Friess H, Di Mola FF, Tang WH, Kubulus D, Brigstock D, et al: Connective tissue growth factor gene expression alters tumor progression in esophageal cancer. World J Surg 2002;26:420-427.
5. Altorki NK, Girardi L, Skinner DB: En bloc esophagectomy improves survival for stage III esophageal cancer. J Thorac Cardiovasc Surg 1997;114:948-955.
6. Surgical resection with or without preoperative chemotherapy in oesophageal cancer: A randomised controlled trial. Lancet 2002;359:1727-1733.
7. Earlam R, Cunha-Melo JR: Oesophageal squamous cell carcinoma. I. A critical review of surgery. Br J Surg 1980;67:381-390.
8. Earlam R, Cunha-Melo JR: Oesophogeal squamous cell carcinoms. II. A critical view of radiotherapy. Br J Surg 1980;67:457-461.
9. Junginger T, Dutkowski P: Selective approach to the treatment of oesophageal cancer. Br J Surg 1996;83:1473-1477.
10. Lerut T, De Leyn P, Coosemans W, Van Raemdonck D, Scheys I, LeSaffre E: Surgical strategies in esophageal carcinoma with emphasis on radical lymphadenectomy. Ann Surg 1992;216:583-590.
11. Nigro JJ, Hagen JA, DeMeester TR, DeMeester SR, Theisen J, Peters JH, et al: Occult esophageal adenocarcinoma: Extent of disease and implications for effective therapy. Ann Surg 1999;230:433-438.
12. van Sandick JW, van Lanschot JJ, Kuiken BW, Tytgat GN, Offerhaus GJ, Obertop H: Impact of endoscopic biopsy surveillance of Barrett's oesophagus on pathological stage and clinical outcome of Barrett's carcinoma. Gut 1998;43:216-222.
13. Ell C, May A, Gossner L, Pech O, Gunter E, Mayer G, et al: Endoscopic mucosal resection of early cancer and high-grade dysplasia in Barrett's esophagus. Gastroenterology 2000;118:670-677.
14. Sibille A, Lambert R, Souquet JC, Sabben G, Descos F: Long-term survival after photodynamic therapy for esophageal cancer. Gastroenterology 1995;108:337-344.
15. Schilling M, Buchler MW: Fundus rotation gastroplasty. Dig Surg 1999;16:175-177.
16. Buchler MW, Baer HU, Seiler C, Schilling M: A technique for gastroplasty as a substitute for the esophagus: Fundus rotation gastroplasty. J Am Coll Surg 1996;182:241-245.
17. Dittler HJ, Siewert JR: Role of endoscopic ultrasonography in esophageal carcinoma. Endoscopy 1993;25:156-161.
18. Peters JH, Hoeft SF, Heimbucher J, Bremner RM, DeMeester TR, Bremner CG, et al: Selection of patients for curative or palliative resection of esophageal cancer based on preoperative endoscopic ultrasonography. Arch Surg 1994;129:534-539.
19. Hagen JA, DeMeester SR, Peters JH, Chandrasoma P, DeMeester TR: Curative resection for esophageal adenocarcinoma: Analysis of 100 en bloc esophagectomies. Ann Surg 2001;234:520-530.
20. Blom D, Peters JH, DeMeester TR: Controversies in the current therapy of carcinoma of the esophagus. J Am Coll Surg 2002;195:241-250.
21. Kelsen DP, Ginsberg R, Pajak TF, Sheahan DG, Gunderson L, Mortimer J, et al: Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med 1998;339:1979-1984.
22. Orringer MB, Marshall B, Iannettoni MD: Transhiatal esophagectomy: Clinical experience and refinements. Ann Surg 1999;230:392-400.
23. Hagen JA, Peters JH, DeMeester TR: Superiority of extended en bloc esophagogastrectomy for carcinoma of the lower esophagus and cardia. J Thorac Cardiovasc Surg 1993;106:850-858.
24. Skinner DB, Dowlatshahi KD, DeMeester TR: Potentially curable cancer of the esophagus. Cancer 1982;50(11 suppl):2571-2575.
25. Skinner DB: En bloc resection for neoplasms of the esophagus and cardia. J Thorac Cardiovasc Surg 1983;85:59-71.
26. Nigro JJ, DeMeester SR, Hagen JA, DeMeester TR, Peters JH, Kiyabu M, et al: Node status in transmural esophageal adenocarcinoma and outcome after en bloc esophagectomy. J Thorac Cardiovasc Surg 1999;117:960-968.
27. Isono K, Sato H, Nakayama K: Results of a nationwide study on the three-field lymph node dissection of esophageal cancer. Oncology 1991;48:411-420.
28. Isono K, Onoda S, Okuyama K, Sato H: Recurrence of intrathoracic esophageal cancer. Jpn J Clin Oncol 1985;15:49-60.
29. Matsubara T, Ueda M, Yanagida O, Nakajima T, Nishi M: How extensive should lymph node dissection be for cancer of the thoracic esophagus? J Thorac Cardiovasc Surg 1994;107:1073-1078.
30. Nishimaki T, Suzuki T, Kanda T, Obinata I, Komukai S, Hatakeyama K: Extended radical esophagectomy for superficially invasive carcinoma of the esophagus. Surgery 1999;125:142-147.
31. Tabira Y, Okuma T, Kondo K, Kitamura N: Indications for three-field dissection followed by esophagectomy for advanced carcinoma of the thoracic esophagus. J Thorac Cardiovasc Surg 1999;117:239-245.
32. Siewert JR, Stein HJ, Feith M, Bruecher BL, Bartels H, Fink U: Histologic tumor type is an independent prognostic parameter in esophageal cancer: Lessons from more than 1,000 consecutive resections at a single center in the Western world. Ann Surg 2001;234:360-367.
33. Hofstetter W, Swisher SG, Correa AM, Hess K, Putnam JB Jr, Ajani JA, et al: Treatment outcomes of resected esophageal cancer. Ann Surg 2002;236:376-384.
34. Altorki N, Skinner D: Should en bloc esophagectomy be the standard of care for esophageal carcinoma? Ann Surg 2001;234:581-587.
35. Law S, Wong J: Two-field dissection is enough for esophageal cancer. Dis Esophagus 2001;14:98-103.
36. Bardini R, Bonavina L, Asolati M, Ruol A, Castoro C, Tiso E: Single-layered cervical esophageal anastomoses: A prospective study of two suturing techniques. Ann Thorac Surg 1994;58:1087-1089.
37. Dewar L, Gelfand G, Finley RJ, Evans K, Inculet R, Nelems B: Factors affecting cervical anastomotic leak and stricture formation following esophagogastrectomy and gastric tube interposition. Am J Surg 1992;163:484-489.
38. Schilling MK, Eichenberger M, Wagener V, Stoupis C, Buchler MW: Impact of fundus rotation gastroplasty on anastomotic complications after cervical and thoracic oesophagogastrostomies: A prospective non-randomised study. Eur J Surg 2001;167:110-114.
39. Huttl TP, Wichmann MW, Geiger TK, Schildberg FW, Furst H: Techniques and results of esophageal cancer surgery in Germany. Langenbecks Arch Surg 2002;387:125-129.
40. Chasseray VM, Kiroff GK, Buard JL, Launois B: Cervical or thoracic anastomosis for esophagectomy for carcinoma. Surg Gynecol Obstet 1989;169:55-62.
41. Giuli R, Sancho-Garnier H: Diagnostic, therapeutic, and prognostic features of cancers of the esophagus: results of the international prospective study conducted by the OESO group (790 patients). Surgery 1986;99:614-622.
42. Schroder W, Baldus SE, Monig SP, Zirbes TK, Beckurts TK, Holscher AH: Lesser curvature lymph node metastases with esophageal squamous cell carcinoma: Implications for gastroplasty. World J Surg 2001;25:1125-1128.
43. Schilling MK, Mettler D, Redaelli C, Buchler MW: Circulatory and anatomic differences among experimental gastric tubes as esophageal replacement. World J Surg 1997;21:992-997.
44. Furst H, Huttl TP, Lohe F, Schildberg FW: German experience with colon interposition grafting as an esophageal substitute. Dis Esophagus 2001;14:131-134.
45. Mansour KA, Bryan FC, Carlson GW: Bowel interposition for esophageal replacement: twenty-five-year experience. Ann Thorac Surg 1997;64:752-756.
46. Thomas P, Fuentes P, Giudicelli R, Reboud E: Colon interposition for esophageal replacement: current indications and long-term function. Ann Thorac Surg 1997;64:757-764.
47. DeMeester TR, Johansson KE, Franze I, Eypasch E, Lu CT, McGill JE, et al: Indications, surgical technique, and long-term functional results of colon interposition or bypass. Ann Surg 1988;208:460-474.
48. Bartels H, Stein HJ, Siewert JR: Preoperative risk analysis and postoperative mortality of oesophagectomy for resectable oesophageal cancer. Br J Surg 1998;85:840-844.
49. Furst H, Hartl WH, Lohe F, Schildberg FW: Colon interposition for esophageal replacement: An alternative technique based on the use of the right colon. Ann Surg 2000;231:173-178.
50. Kolh P, Honoré P, Degauque C, Gielen J, Gérard P, Jacquet N: Early stage results after oesophageal resection for malignancy - colon interposition vs. gastric pull-up. Eur J Cardiothorac Surg 2000;18:293-300.
51. van Lanschot JJ, Hop WC, Voormolen MH, van Deelen RA, Blomjous JG, Tilanus HW: Quality of palliation and possible benefit of extra-anatomic reconstruction in recurrent dysphagia after resection of carcinoma of the esophagus. J Am Coll Surg 1994;179:705-713.
52. Urschel JD, Urschel DM, Miller JD, Bennett WF, Young JE: A meta-analysis of randomized controlled trials of route of reconstruction after esophagectomy for cancer. Am J Surg 2001;182:470-475.
53. Urschel JD: Does the interponate affect outcome after esophagectomy for cancer? Dis Esophagus 2001;14:124-130.
54. Urschel JD: Esophagogastrostomy anastomotic leaks complicating esophagectomy: A review. Am J Surg 1995;169:634-640.
55. Young MM, Deschamps C, Trastek VF, Allen MS, Miller DL, Schleck CD, et al: Esophageal reconstruction for benign disease: Early morbidity, mortality, and functional results. Ann Thorac Surg 2000;70:1651-1655.
56. May A, Gossner L, Pech O, Muller H, Vieth M, Stolte M, et al: Intraepithelial high-grade neoplasia and early adenocarcinoma in short-segment Barrett's esophagus (SSBE): Curative treatment using local endoscopic treatment techniques. Endoscopy 2002;34:604-610.
57. Banki F, Mason RJ, DeMeester SR, Hagen JA, Balaji NS, Crookes PF, et al: Vagal-sparing esophagectomy: A more physiologic alternative. Ann Surg 2002;236:324-335.
58. Bosset JF, Gignoux M, Triboulet JP, Tiret E, Mantion G, Elias D, et al: Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. N Engl J Med 1997;337:161-167.
59. Lehnert T: Multimodal therapy for squamous carcinoma of the oesophagus. Br J Surg 1999;86:727-739.
60. Samel S, Hofheinz R, Hundt A, Sturm J, Knoll MR, Wenz F, et al: Neoadjuvant radio-chemotherapy of adenocarcinoma of the oesophagogastric junction. Onkologie 2001;24:278-282.
61. Schlag P: Randomized study of preoperative chemotherapy in squamous cell cancer of the esophagus. CAO Esophageal Cancer Study Group. Chirurg 1992;63:709-714.
62. Urba SG, Orringer MB, Perez-Tamayo C, Bromberg J, Forastiere A: Concurrent preoperative chemotherapy and radiation therapy in localized esophageal adenocarcinoma. Cancer 1992;69:285-291.
63. Geh JI, Crellin AM, Glynne-Jones R: Preoperative (neoadjuvant) chemoradiotherapy in oesophageal cancer. Br J Surg 2001;88:338-356.
64. Kane JM III, Shears LL, Ribeiro U, Clark MR, Peterson M, Landreneau RJ, et al: Is esophagectomy following upfront chemoradiotherapy safe and necessary? Arch Surg 1997;132:481-485.
65. Apinop C, Puttisak P, Preecha N: A prospective study of combined therapy in esophageal cancer. Hepatogastroenterology 1994;41:391-393.
66. Le Prise E, Etienne PL, Meunier B, Maddern G, Ben Hassel M, Gedouin D, et al: A randomized study of chemotherapy, radiation therapy, and surgery versus surgery for localized squamous cell carcinoma of the esophagus. Cancer 1994;73:1779-1784.
67. Nygaard K, Hagen S, Hansen HS, Hatlevoll R, Hultborn R, Jakobsen A, et al: Pre-operative radiotherapy prolongs survival in operable esophageal carcinoma: A randomized, multicenter study of pre-operative radiotherapy and chemotherapy. The second Scandinavian trial in esophageal cancer. World J Surg 1992;16(6):1104-1109.
68. Walsh TN, Noonan N, Hollywood D, Kelly A, Keeling N, Hennessy TP: A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 1996;335:462-467.
69. Nygaard K, Hagen S, Hansen HS, Hatlevoll R, Hultborn R, Jakobsen A, et al: Pre-operative radiotherapy prolongs survival in operable esophageal carcinoma: A randomized, multicenter study of pre-operative radiotherapy and chemotherapy. The second Scandinavian trial in esophageal cancer. World J Surg 1992;16:1104-1109.
70. Apinop C, Puttisak P, Preecha N: A prospective study of combined therapy in esophageal cancer. Hepatogastroenterology 1994;41:391-393.
71. Walsh TN, Noonan N, Hollywood D, Kelly A, Keeling N, Hennessy TP: A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 1996;335:462-467.